Hasnain Faheem
President & CEO
Hasnain Faheem has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including GOSS, KURA, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jan 5, 2026.
On the most recent filing, Hasnain Faheem is listed as Director at Kura Oncology, Inc. Inside the rolling window, Hasnain Faheem reported no open-market purchases and 1 open-market sale totaling $110K in KURA.
Companies traded
Other insiders at GOSS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$110K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hasnain Faheem made?
Hasnain Faheem has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including GOSS, KURA since 2025.
Which companies does Hasnain Faheem trade?
Hasnain Faheem has filed SEC Form 4 disclosures for 2 companies, including GOSS, KURA.
When was Hasnain Faheem's most recent SEC Form 4 filing?
Hasnain Faheem's most recent SEC Form 4 filing on Tracefour is dated Jan 5, 2026.
What is Hasnain Faheem's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hasnain Faheem is listed as President & CEO.
What is Hasnain Faheem's total buy and sell value in the current window?
Inside the rolling retention window, Hasnain Faheem bought $0 and sold $110K based on SEC Form 4 filings.
What was Hasnain Faheem's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 KURA shares on 2025-12-09, worth $110K, per SEC Form 4 filings.